Given FOXA1’s known function as a pioneer factor, it would be interesting to determine whether FOXA1 plays a role in binding and “pre-marking” these Enza-R CRPC noncanonical binding sites before AR binds (Figure 3), as was observed previously in the transition from primary PCa to mCRPC (11). The gene discussed is AR; the disease is posterior cortical atrophy.